Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib von Groenland, Stefanie L., Martínez-Chávez, Alejandra, van Dongen, Marloes G. J., Beijnen, Jos H., Schinkel, Alfred H., Huitema, Alwin D. R., Steeghs, Neeltje

Volltext

Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study von Shapira-Frommer, Ronnie, Mileshkin, Linda, Manzyuk, Ludmila, Penel, Nicolas, Burge, Matthew, Piha-Paul, Sarina A, Girda, Eugenia, Lopez Martin, Jose A, van Dongen, Marloes G J, Italiano, Antoine, Xu, Lei, Jin, Fan, Norwood, Kevin, Ott, Patrick A

Volltext

Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer von Molenaar‐Kuijsten, Laura, Braal, C. Louwrens, Groenland, Stefanie L., Vries, Niels, Rosing, Hilde, Beijnen, Jos H., Koolen, Stijn L.W., Vulink, Annelie J.E., Dongen, Marloes G.J., Mathijssen, Ron H.J., Huitema, Alwin D.R., Steeghs, Neeltje

Volltext

First proof of pharmacology in humans of a novel glucagon receptor antisense drug von van Dongen, Marloes G. J., Geerts, Bart F., Morgan, Erin S., Brandt, Teresa A., de Kam, Marieke L., Romijn, Johannes A., Cohen, Adam F., Bhanot, Sanjay, Burggraaf, Jacobus

Volltext

Mathematical modeling of the glucagon challenge test von Masroor, Saeed, van Dongen, Marloes G. J., Alvarez-Jimenez, Ricardo, Burggraaf, Koos, Peletier, Lambertus A., Peletier, Mark A.

Volltext

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial von Nederlof, Iris, Isaeva, Olga I, de Graaf, Manon, Gielen, Robbert C.A.M, Bakker, Noor A.M, Rolfes, Adrianne L, Garner, Hannah, Boeckx, Bram, Traets, Joleen J.H, Mandjes, Ingrid A.M, de Maaker, Michiel, van Brussel, Thomas, Chelushkin, Maksim, Champanhet, Elisa, Lopez-Yurda, Marta, van de Vijver, Koen, van den Berg, Jose G, Hofland, Ingrid, Klioueva, Natasja, Mann, Ritse M, Loo, Claudette E, van Duijnhoven, Frederieke H, Skinner, Victoria, Luykx, Sylvia, Kerver, Emile, Kalashnikova, Ekaterina, van Dongen, Marloes G.J, Sonke, Gabe S, Linn, Sabine C, Blank, Christian U, de Visser, Karin E, Salgado, Roberto, Wessels, Lodewyk F.A, Drukker, Caroline A, Schumacher, Ton N, Horlings, Hugo M, Lambrechts, Diether, Kok, Marleen

Volltext

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study von Marabelle, Aurelien, Cassier, Philippe A, Fakih, Marwan, Kao, Steven, Nielsen, Dorte, Italiano, Antoine, Guren, Tormod Kyrre, van Dongen, Marloes G J, Spencer, Kristen, Bariani, Giovanni Mendonca, Ascierto, Paolo A, Santoro, Armando, Shah, Manisha, Asselah, Jamil, Iqbal, Syma, Takahashi, Shunji, Piha-Paul, Sarina A, Ott, Patrick A, Chatterjee, Arkendu, Jin, Fan, Norwood, Kevin, Delord, Jean-Pierre

Volltext

PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial von Voorwerk, Leonie, Isaeva, Olga I, Horlings, Hugo M, Balduzzi, Sara, Chelushkin, Maksim, Bakker, Noor A M, Champanhet, Elisa, Garner, Hannah, Sikorska, Karolina, Loo, Claudette E, Kemper, Inge, Mandjes, Ingrid A M, de Maaker, Michiel, van Geel, Jasper J L, Boers, Jorianne, de Boer, Maaike, Salgado, Roberto, van Dongen, Marloes G J, Sonke, Gabe S, de Visser, Karin E, Schumacher, Ton N, Blank, Christian U, Wessels, Lodewyk F A, Jager, Agnes, Tjan-Heijnen, Vivianne C G, Schröder, Carolien P, Linn, Sabine C, Kok, Marleen

Volltext